Regentis Biomaterials Ltd (RGNT)

$1.96 -0.20 (-9.26%)
Market Cap 11.45M
Revenue (ttm) 0.00
Net Income (ttm) -13.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.25
Volume 23,600
Avg Vol 13,452
Day's Range N/A - N/A
Shares Out 5.18M
Stochastic %K 43%
Beta N/A
Analysts Strong Sell
Price Target $10.00

Company Profile

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 972 9 960 1917
Address:
60, Medinat Hayehudim, Entrance C Herzlia Pituach, Herzliya, Israel
NetworkNewsWire
NetworkNewsWire May. 27 at 5:12 PM
$RGNT Is ‘One to Watch’ https://ibn.fm/3YfCb
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 22 at 8:04 PM
$RGNT and the Off-the-Shelf Opportunity in Knee Cartilage Repair https://ibn.fm/aJs3w
0 · Reply
DivineProvidence
DivineProvidence May. 20 at 8:41 PM
$RGNT who here thinks this does 3X to 5X in a single day?
0 · Reply
DivineProvidence
DivineProvidence May. 20 at 8:39 PM
$RGNT who here thinks this does a 3x to 5X in a single day? 
0 · Reply
DivineProvidence
DivineProvidence May. 20 at 4:44 PM
$RGNT we’ve seen this movie before with other small biotechs. They just go wild one day and those not in it are left wondering
0 · Reply
TA_Kongen
TA_Kongen May. 20 at 3:30 PM
$RGNT Teasing the move. Very very thin.
0 · Reply
sneeds_feed_N_seed
sneeds_feed_N_seed May. 20 at 3:05 PM
$RGNT
0 · Reply
sneeds_feed_N_seed
sneeds_feed_N_seed May. 17 at 5:30 PM
$RGNT I need to add more here, could explode to handsome multi bagger. Already deploying in Europe and on track for FDA approval for expansion into US market. https://www.towardshealthcare.com/news/regentis-biomaterials-us-clinical-site-expansion-gelrinc What could possibly go wrong?
0 · Reply
LTFG
LTFG May. 15 at 2:11 PM
$RGNT Took a starter
0 · Reply
TA_Kongen
TA_Kongen May. 4 at 2:11 PM
$RGNT S-1 active. So very thin. Prob see some kind of move before effect and offering. Thinkequity is the player.
0 · Reply
Latest News on RGNT
Regentis Biomaterials enters collaboration with Humanitas Research Hospital

2026-04-16T12:51:22.000Z - 5 weeks ago

Regentis Biomaterials enters collaboration with Humanitas Research Hospital

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon

Apr 16, 2026, 8:30 AM EDT - 5 weeks ago

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon

Regentis Biomaterials develops and patents solvent-free manufacturing process

2026-03-17T13:07:43.000Z - 2 months ago

Regentis Biomaterials develops and patents solvent-free manufacturing process

Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

Mar 17, 2026, 8:30 AM EDT - 2 months ago

Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

Regentis Biomaterials initiated with a Buy at ThinkEquity

2026-03-02T11:39:51.000Z - 3 months ago

Regentis Biomaterials initiated with a Buy at ThinkEquity

Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update

Feb 24, 2026, 4:15 PM EST - 3 months ago

Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update

Regentis Biomaterials appoints Galit Reke as CMO

2026-02-19T13:57:38.000Z - 3 months ago

Regentis Biomaterials appoints Galit Reke as CMO

Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair

Feb 19, 2026, 8:30 AM EST - 3 months ago

Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair

Regentis Biomaterials expands European clinical site network

2026-02-17T13:45:16.000Z - 3 months ago

Regentis Biomaterials expands European clinical site network

Regentis Biomaterials appoints Ori Gon as CFO, CBO

2026-02-04T14:01:34.000Z - 4 months ago

Regentis Biomaterials appoints Ori Gon as CFO, CBO

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial

Feb 4, 2026, 8:33 AM EST - 4 months ago

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial

Regentis Biomaterials expanding Phase III GelrinC clinical site network

2026-01-29T13:50:51.000Z - 4 months ago

Regentis Biomaterials expanding Phase III GelrinC clinical site network

Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

Jan 29, 2026, 8:33 AM EST - 4 months ago

Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

Regentis Biomaterials Ltd trading resumes

2026-01-28T16:25:13.000Z - 4 months ago

Regentis Biomaterials Ltd trading resumes

Regentis Biomaterials Ltd trading halted, volatility trading pause

2026-01-28T16:05:14.000Z - 4 months ago

Regentis Biomaterials Ltd trading halted, volatility trading pause

Regentis Biomaterials announces long-term imaging data on GelrinC

2026-01-20T14:00:22.000Z - 4 months ago

Regentis Biomaterials announces long-term imaging data on GelrinC

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

Jan 20, 2026, 8:33 AM EST - 4 months ago

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

Regentis Biomaterials Ltd trading resumes

2026-01-16T16:05:30.000Z - 4 months ago

Regentis Biomaterials Ltd trading resumes

Regentis Biomaterials Ltd trading halted, volatility trading pause

2026-01-16T16:00:15.000Z - 4 months ago

Regentis Biomaterials Ltd trading halted, volatility trading pause

Regentis Biomaterials announces publication of GelrinC follow-up results

2026-01-06T14:00:16.000Z - 5 months ago

Regentis Biomaterials announces publication of GelrinC follow-up results

Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation

Jan 6, 2026, 8:21 AM EST - 5 months ago

Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation

Regentis Biomaterials granted U.S. patent for GelrinC

2025-12-18T13:50:22.000Z - 5 months ago

Regentis Biomaterials granted U.S. patent for GelrinC

Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC

Dec 18, 2025, 8:35 AM EST - 5 months ago

Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC

Opening Day: Regentis Biomaterials raises $10M in IPO

2025-12-08T15:30:10.000Z - 6 months ago

Opening Day: Regentis Biomaterials raises $10M in IPO

HYNE OTH PARK POAS SMJF

Regentis Biomaterials commences trading on NYSE

2025-12-08T13:55:06.000Z - 6 months ago

Regentis Biomaterials commences trading on NYSE

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Dec 5, 2025, 4:10 PM EST - 6 months ago

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

Dec 3, 2025, 7:23 PM EST - 6 months ago

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

Israeli hydrogel implant developer Regentis Biomaterials files and sets terms for a $10 million US IPO

Mar 11, 2025, 9:16 AM EDT - 1 year ago

Israeli hydrogel implant developer Regentis Biomaterials files and sets terms for a $10 million US IPO

Regentis Biomaterials IPO Registration Document (F-1)

Mar 11, 2025, 6:09 AM EDT - 1 year ago

Regentis Biomaterials IPO Registration Document (F-1)

NetworkNewsWire
NetworkNewsWire May. 27 at 5:12 PM
$RGNT Is ‘One to Watch’ https://ibn.fm/3YfCb
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 22 at 8:04 PM
$RGNT and the Off-the-Shelf Opportunity in Knee Cartilage Repair https://ibn.fm/aJs3w
0 · Reply
DivineProvidence
DivineProvidence May. 20 at 8:41 PM
$RGNT who here thinks this does 3X to 5X in a single day?
0 · Reply
DivineProvidence
DivineProvidence May. 20 at 8:39 PM
$RGNT who here thinks this does a 3x to 5X in a single day? 
0 · Reply
DivineProvidence
DivineProvidence May. 20 at 4:44 PM
$RGNT we’ve seen this movie before with other small biotechs. They just go wild one day and those not in it are left wondering
0 · Reply
TA_Kongen
TA_Kongen May. 20 at 3:30 PM
$RGNT Teasing the move. Very very thin.
0 · Reply
sneeds_feed_N_seed
sneeds_feed_N_seed May. 20 at 3:05 PM
$RGNT
0 · Reply
sneeds_feed_N_seed
sneeds_feed_N_seed May. 17 at 5:30 PM
$RGNT I need to add more here, could explode to handsome multi bagger. Already deploying in Europe and on track for FDA approval for expansion into US market. https://www.towardshealthcare.com/news/regentis-biomaterials-us-clinical-site-expansion-gelrinc What could possibly go wrong?
0 · Reply
LTFG
LTFG May. 15 at 2:11 PM
$RGNT Took a starter
0 · Reply
TA_Kongen
TA_Kongen May. 4 at 2:11 PM
$RGNT S-1 active. So very thin. Prob see some kind of move before effect and offering. Thinkequity is the player.
0 · Reply
MotionOffense78
MotionOffense78 May. 1 at 10:04 PM
$RGNT load this drop.
1 · Reply
sydneyinsydney
sydneyinsydney Apr. 27 at 8:44 PM
$RGNT this will pump eventually. gonna bet $100. high roller
0 · Reply
itrekntravel
itrekntravel Apr. 1 at 5:23 PM
$RGNT Don't know about its prospects, but i do know i had to let go of my shares. No movement, no news = stagnant when i could trade/invest those funds elsewhere. Serious GL to all! ☘️
0 · Reply
choyler97
choyler97 Mar. 11 at 5:49 PM
$RGNT Is this company and stock even alive anymore????
0 · Reply
Victory777777
Victory777777 Mar. 5 at 3:53 PM
$RGNT is the next $BNAI
0 · Reply
sneeds_feed_N_seed
sneeds_feed_N_seed Feb. 27 at 6:45 PM
$RGNT I think here is good to scale in, $6-8 again soon.(?)
0 · Reply
Victory777777
Victory777777 Feb. 23 at 1:24 PM
$NYT $RGNT
0 · Reply
Victory777777
Victory777777 Feb. 19 at 3:14 PM
$RGNT what happened to the stock?
0 · Reply
choyler97
choyler97 Feb. 17 at 9:30 PM
$RGNT So much for taking a chance.
0 · Reply
Ahirman
Ahirman Feb. 17 at 7:42 PM
$RGNT looking for a re-entry wondering if > 3 is a start. We are already 1/2 the offering price
0 · Reply